Abstract(Abstract) #1 Gestational Exposure to an Efavirenz-Containing Compared to a Dolutegravir-Containing Antiretroviral Regimen Is Associated with Lower Anthropometrics at 18 Months of Life among Children HIV-Exposed Uninfected in BotswanaView Abstract
Abstract(Abstract) #2 Infant Safety Following Exposure to Maternal TDF/FTC for HIV Prevention in Utero and Through Breast Milk: IMPAACT 2009View Abstract
Abstract(Abstract) #3 The Impact of Daily Oral PrEP on Maternal Bone Mineral Density During Pregnancy and Postpartum: IMPAACT 2009View Abstract
Abstract(Abstract) #4 Impact of Maternal HIV Status on Maternal and Child Peripheral Blood Immune Markers and Associations with Neurometabolite Profiles at Age 6–7 Years: A South African Birth Cohort StudyView Abstract
Abstract(Abstract) #5 Validation of a Ministry of Health (MoH) HIV Risk Screening Tool for Breastfeeding Women (BFW) in Northern and Central Mozambique (2022 to 2024)View Abstract
Abstract(Abstract) #6 Did HIV-1 Incidence Decline During the DREAMS Program? Lack of Progress for Adolescent Girls and Young WomenView Abstract
Abstract(Abstract) #7 Ugandan Teenage Females with PHIV on DTG Have a Distinct Phenotype Concerning for Future Cardiometabolic RiskView Abstract
Abstract(Abstract) #8 Minimising Risk, Maximising Retention: A Cascade Analysis of Vertical HIV Transmission Prevention among Adolescent Mothers and Their Children in the Eastern Cape Province, South AfricaView Abstract
Abstract(Abstract) #9 Mental Health Challenges and Substance Use Associated with Poor Viral Suppression and Transition Readiness among Adolescents with HIV Transitioning to Adult CareView Abstract
Abstract(Abstract) #10 Outcomes of Children and Young Adolescents Receiving ART Under Family-Based DSD Model at Largest Public ART Clinic in Lilongwe, MalawiView Abstract
Abstract(Abstract) #11 Predictors of Treatment Failure in Children Living with HIV Starting First-Line Antiretroviral Therapy in the ODYSSEY TrialView Abstract
Abstract(Abstract) #12 Factors Associated with HIV-1 DNA Dynamics in Early Treated Children with Perinatal HIVView Abstract
Abstract(Abstract) #13 Efficacy and Safety of Emtricitabine/Tenofovir Alafenamide (F/TAF) Plus Cobicistat-Boosted Protease Inhibitors in Children with HIV-1 Aged 2-<12 Years and Weighing 14-<40 kg: Week 48 OutcomesView Abstract
Abstract(Abstract) #14 Effectiveness and Safety of Dolutegravir (DTG) in Infants and Children Aged Under 12-Years at Start of DTG in Europe and ThailandView Abstract
Abstract(Abstract) #15 Efficacy of Second-Line Dolutegravir- versus Boosted Protease Inhibitor-Based ART in Children and Adolescents Living with HIV at 96 and 144 Weeks: Pooled Analysis of the ODYSSEY and CHAPAS-4 TrialsView Abstract
Abstract(Abstract) #16 Silent Threats and Missed Opportunities: Rethinking Pediatric TB/HIV Co-Infection Diagnosis in the Era of Advanced HIV Treatment and Universal Test-and-TreatView Abstract
Abstract(Abstract) #17 Effect of TB Preventive Treatment on TB Incidence and Non-TB-Related Mortality among Children and Adolescents Living with HIV Initiated on Antiretroviral Therapy in Cameroon, 2020-2022View Abstract
Abstract(Abstract) #18 Infectious Morbidity among Children HIV-Exposed, Uninfected in South Africa: Elevated Risk in Infancy But Not ThereafterView Abstract
Abstract(Abstract) #19 Growth Trajectories Before and After Switching to Dolutegravir in Children Living with HIV in the ODYSSEY TrialView Abstract
Abstract(Abstract) #20 Telomere Length and Neurodevelopmental Outcomes among Children Exposed and Not Exposed to HIV in KenyaView Abstract
Abstract(Abstract) #21 Switching Off Dolutegravir in Pregnancy During the Safety Signal Period: A Multi-Cohort European StudyView Abstract
Abstract(Abstract) #22 Causes of Death among Sub-Saharan African Infants Living with HIV and Hospitalised with Severe Pneumonia Using Minimally Invasive Autopsies in the EMPIRICAL TrialView Abstract
Abstract(Abstract) #23 Association Between Reservoir Size and Markers of Cardiovascular Inflammation in Perinatally Infected Children Living with HIVView Abstract
